Timothy Kennedy, CFO of Biocept, appears to have filed an empty initial statement of beneficial ownership. This form is usually filed as a prelude to a company officer either receiving options or buying company shares, so there may be more to come from Kennedy.
Here is the filing.
To get notified when Biocept makes a similar move, sign up!
Other recent filings from the company include the following:
Biocept Just Filed Its Annual Report:
12. Net Loss per Co... - March 28, 2017
Shareholder Director - March 23, 2017
CFO of Biocept was just granted 16,383 options - March 22, 2017
Biocept's CEO & President was just granted 16,333 options - March 22, 2017
Biocept Reports Fourth Quarter And Full Year 2016 Financial Results - March 7, 2017